The record
Written from the 1 report below. Nothing here is unsourced.
- Retatrutide is an experimental weight-loss drug currently undergoing clinical trials by Eli Lilly and has not yet received regulatory approval for human use.
- Despite this, counterfeit versions are being widely sold on the black market through social media, gyms, and beauty salons.
- Medical experts and the manufacturer have issued stern warnings, as improper use of these substances has already led to hospitalizations and serious side effects.
What to watch next
- Ongoing regulatory efforts by MHRA and other bodies to curb illegal distribution.
- Future FDA and other regulatory approval timelines for the actual drug.
- Increased health complications reported from individuals using illicit versions.
Coverage1
1 report
Indian-language1
All filed from India
Named United Kingdom · United States · Lisa King · Tom Davis · British Islamic Medical Association · Donald O'Shea · Eli Lilly · MHRA · Nas Khattak · Sahira Dar · Sehar Shahid
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.